Weight-Loss Drug Frenzy Cements Novo Nordisk as Europe’s Most Valuable Company

📆 10/13/2023 4:52 AM
📰 BNNBloomberg

⏱ Reading Time:
26 sec. here
2 min. at publisher
📊 Quality Score:
News: 14%
Publisher: 50%

United States News News

United States United States Latest News,United States United States Headlines

Little more than a month since becoming Europe’s most valuable listed company, Novo Nordisk A/S has stretched its lead to almost $90 billion as the buzz around weight-loss drugs gets ever louder.

Israel Latest: IDF Urges Evacuation of Gaza City, Signaling IncursionSt.

James’s Place Says It’s Reviewing Fees; Shares TumbleBlackRock Clients Pull $13 Billion From Long-Term FundsBOE’s Bailey Seeks Ways to Respond Faster When Bank Runs HappenChina’s Credit Growth Beats Expectations on Stronger StimulusIMF Latest: World Bank Says Poorest Need More Funding Than EverUK’s FCA Fines Equifax £11 Million Over Massive Cyber HackNASA Probe Bound for Metal Asteroid to Launch on SpaceX’s Falcon HeavyFrom high flying to burnout, pot industry faces downturn five years...

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Clothing Stocks Seen as Latest Winners From Weight-Loss DrugsThe boom in weight-loss drugs is set to provide a boost to sportswear brands and clothing retailers, according to Deutsche Bank AG analysts.
Source: BNNBloomberg - 🏆 83. / 50 Read more »